Cargando…
A survey of five antidepressant properties influencing clinician’s treatment choices in MDD
INTRODUCTION: The goal of the present work was to examine how clinicians’ perceptions of the properties of antidepressants may influence their choice of antidepressants when treating major depressive disorder (MDD). METHODS: 273 of 682 (40%) clinicians attending a psychopharmacology review course re...
Autores principales: | Papakostas, George I, Hallett, Lindsay A, Smith, Juliana, Tossani, Eliana, Mascarini, Alessandra, Burns, Alana M, Birnbaum, Robert J, Fava, Maurizio, Alpert, Jonathan E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654520/ https://www.ncbi.nlm.nih.gov/pubmed/19300547 |
Ejemplares similares
-
Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review
por: Salloum, Naji C., et al.
Publicado: (2020) -
The clinical utility of newer antidepressant agents: Understanding the role in management of MDD
por: Waters, Kristin
Publicado: (2022) -
Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021) -
White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
por: Breit, S., et al.
Publicado: (2022) -
Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
por: Leutner, Michael, et al.
Publicado: (2021)